TB-500 (CAS 885340-08-9) is a synthetic peptide derived from the actin-binding region of Thymosin Beta-4, studied for its interaction with cellular migration, actin regulation, and tissue-related signalling pathways. PhaseOne supplies TB-500 to Australian researchers as a high-purity lyophilised powder, independently HPLC verified at ≥98% purity per batch.
TB-500 is among the most requested research peptides in Australia, manufactured to research-grade standards and independently third-party tested for identity and consistency, with every order shipped Australia-wide. (!) Full Certificate of Analysis available for every batch view here.
TB-500 is a synthetic peptide modelled on Thymosin Beta-4's actin-binding domain, frequently discussed within Australian peptide research communities alongside recovery, cellular migration, and tissue-related research.
While both are studied in recovery-related research, TB-500 is investigated primarily for actin regulation and cell migration, whereas BPC-157 research more commonly focuses on gut and regenerative signalling. The two are frequently studied together as a blend. (!) See our BPC-157 + TB-500 blend.
Unreconstituted TB-500 should be kept refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research preparation. (!) Read our reconstitution guide.
Every batch of TB-500 sold across Australia by PhaseOne is supported by third-party HPLC testing and a full Certificate of Analysis.
TB-500 refers to a synthetic fragment derived from Thymosin Beta-4's active region, rather than the full-length native protein - a distinction worth understanding before comparing research literature.
Yes - we supply a combined preparation for researchers studying both peptides together. (!) View our BPC-157 or BPC-157 + TB-500 Blend.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
